Skip to main content
STELLA PHARMA CORPORATION logo

STELLA PHARMA CORPORATION — Investor Relations & Filings

Ticker · 4888 ISIN · JP3399680002 T Manufacturing
Open in API
Filings indexed 47 across all filing types
Latest filing 2021-04-05 Share Issue/Capital Cha…
Country JP Japan
Listing T 4888

About STELLA PHARMA CORPORATION

https://stella-pharma.co.jp/

Stella Pharma Corporation is a pharmaceutical company focused on the research and development of therapeutic drugs. The company specializes in boron compounds for Boron Neutron Capture Therapy (BNCT), a form of targeted radiation therapy for cancer. As a pioneer in the field, Stella Pharma developed the boron-based drug used in the first approved BNCT treatment for unresectable head and neck cancers. Its development pipeline is focused on expanding the application of BNCT to other difficult-to-treat malignancies, with clinical trials investigating its use for conditions such as cutaneous angiosarcoma.

Recent filings

Filing Released Lang Actions
訂正有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 98% confidence The document is a 'Securities Registration Statement' (有価証券届出書) for an Initial Public Offering (IPO) by Stella Pharma Corporation. It details the offering terms, share issuance, underwriting, and use of proceeds. In the context of Japanese regulatory filings, this is a formal registration statement for a new public offering, which falls under the 'Regulatory Filings' category as it is a primary disclosure document for capital markets.
2021-04-05 Japanese
有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 98% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kinki Finance Bureau in Japan. It details a new share issuance (IPO) for Stella Pharma Corporation, including offering terms, underwriting details, and the use of proceeds. This type of filing is a regulatory document required for public offerings and does not fit into the specific categories of annual reports, earnings releases, or proxy statements. Given the nature of the document as a formal regulatory filing for a capital raise, it is classified as a Regulatory Filing (RNS).
2021-03-19 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.